These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 38528148)
21. Analysis of Mycobacterium tuberculosis Uptake by Alveolar Macrophages after Ex vivo Expansion Indicates Processing Host Cells with Pathogen Actually from Lung Tissue of Patients with Pulmonary Tuberculosis. Ufimtseva E; Eremeeva N; Bayborodin S; Umpeleva T; Vakhrusheva D; Skornyakov S Int J Mycobacteriol; 2020; 9(2):176-184. PubMed ID: 32474540 [TBL] [Abstract][Full Text] [Related]
22. Mycobacterium tuberculosis with different virulence reside within intact phagosomes and inhibit phagolysosomal biogenesis in alveolar macrophages of patients with pulmonary tuberculosis. Ufimtseva E; Eremeeva N; Bayborodin S; Umpeleva T; Vakhrusheva D; Skornyakov S Tuberculosis (Edinb); 2019 Jan; 114():77-90. PubMed ID: 30711161 [TBL] [Abstract][Full Text] [Related]
23. Apoptosis genes in human alveolar macrophages infected with virulent or attenuated Mycobacterium tuberculosis: a pivotal role for tumor necrosis factor. Spira A; Carroll JD; Liu G; Aziz Z; Shah V; Kornfeld H; Keane J Am J Respir Cell Mol Biol; 2003 Nov; 29(5):545-51. PubMed ID: 12748057 [TBL] [Abstract][Full Text] [Related]
24. Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. Hirsch CS; Ellner JJ; Russell DG; Rich EA J Immunol; 1994 Jan; 152(2):743-53. PubMed ID: 8283049 [TBL] [Abstract][Full Text] [Related]
25. Differential Targeting of c-Maf, Bach-1, and Elmo-1 by microRNA-143 and microRNA-365 Promotes the Intracellular Growth of Tamgue O; Gcanga L; Ozturk M; Whitehead L; Pillay S; Jacobs R; Roy S; Schmeier S; Davids M; Medvedeva YA; Dheda K; Suzuki H; Brombacher F; Guler R Front Immunol; 2019; 10():421. PubMed ID: 30941122 [No Abstract] [Full Text] [Related]
26. Extracellular Vesicles Released from Alvarez-Jiménez VD; Leyva-Paredes K; García-Martínez M; Vázquez-Flores L; García-Paredes VG; Campillo-Navarro M; Romo-Cruz I; Rosales-García VH; Castañeda-Casimiro J; González-Pozos S; Hernández JM; Wong-Baeza C; García-Pérez BE; Ortiz-Navarrete V; Estrada-Parra S; Serafín-López J; Wong-Baeza I; Chacón-Salinas R; Estrada-García I Front Immunol; 2018; 9():272. PubMed ID: 29520273 [TBL] [Abstract][Full Text] [Related]
27. Su H; Weng S; Luo L; Sun Q; Lin T; Ma H; He Y; Wu J; Wang H; Zhang W; Xu Y Emerg Microbes Infect; 2024 Dec; 13(1):2322663. PubMed ID: 38380651 [TBL] [Abstract][Full Text] [Related]
28. Mycobacterium tuberculosis cording in alveolar macrophages of patients with pulmonary tuberculosis is likely associated with increased mycobacterial virulence. Ufimtseva EG; Eremeeva NI; Petrunina EM; Umpeleva TV; Bayborodin SI; Vakhrusheva DV; Skornyakov SN Tuberculosis (Edinb); 2018 Sep; 112():1-10. PubMed ID: 30205961 [TBL] [Abstract][Full Text] [Related]
29. Cholesterol oxidase is indispensable in the pathogenesis of Mycobacterium tuberculosis. Klink M; Brzezinska M; Szulc I; Brzostek A; Kielbik M; Sulowska Z; Dziadek J PLoS One; 2013; 8(9):e73333. PubMed ID: 24039915 [TBL] [Abstract][Full Text] [Related]
30. Oxidized low-density lipoprotein (oxLDL) supports Mycobacterium tuberculosis survival in macrophages by inducing lysosomal dysfunction. Vrieling F; Wilson L; Rensen PCN; Walzl G; Ottenhoff THM; Joosten SA PLoS Pathog; 2019 Apr; 15(4):e1007724. PubMed ID: 30998773 [TBL] [Abstract][Full Text] [Related]
31. TLR2 is non-redundant in the population and subpopulation responses to Jani C; Solomon SL; Peters JM; Pringle SC; Hinman AE; Boucau J; Bryson BD; Barczak AK mSystems; 2023 Aug; 8(4):e0005223. PubMed ID: 37439558 [TBL] [Abstract][Full Text] [Related]
32. Mycobacterium tuberculosis growth control by lung macrophages and CD8 cells from patient contacts. Carranza C; Juárez E; Torres M; Ellner JJ; Sada E; Schwander SK Am J Respir Crit Care Med; 2006 Jan; 173(2):238-45. PubMed ID: 16210664 [TBL] [Abstract][Full Text] [Related]
35. MIR144* inhibits antimicrobial responses against Mycobacterium tuberculosis in human monocytes and macrophages by targeting the autophagy protein DRAM2. Kim JK; Lee HM; Park KS; Shin DM; Kim TS; Kim YS; Suh HW; Kim SY; Kim IS; Kim JM; Son JW; Sohn KM; Jung SS; Chung C; Han SB; Yang CS; Jo EK Autophagy; 2017 Feb; 13(2):423-441. PubMed ID: 27764573 [TBL] [Abstract][Full Text] [Related]
36. Silencing miR-125b-5p attenuates inflammatory response and apoptosis inhibition in mycobacterium tuberculosis-infected human macrophages by targeting DNA damage-regulated autophagy modulator 2 (DRAM2). Liu G; Wan Q; Li J; Hu X; Gu X; Xu S Cell Cycle; 2020 Nov; 19(22):3182-3194. PubMed ID: 33121314 [TBL] [Abstract][Full Text] [Related]
37. Mycobacterium tuberculosis PPE51 Inhibits Autophagy by Suppressing Toll-Like Receptor 2-Dependent Signaling. Strong EJ; Wang J; Ng TW; Porcelli SA; Lee S mBio; 2022 Jun; 13(3):e0297421. PubMed ID: 35467412 [TBL] [Abstract][Full Text] [Related]
38. Ex vivo expansion of alveolar macrophages with Mycobacterium tuberculosis from the resected lungs of patients with pulmonary tuberculosis. Ufimtseva E; Eremeeva N; Petrunina E; Umpeleva T; Karskanova S; Bayborodin S; Vakhrusheva D; Kravchenko M; Skornyakov S PLoS One; 2018; 13(2):e0191918. PubMed ID: 29401466 [TBL] [Abstract][Full Text] [Related]